14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $44.15 $44.15 Friday, 26th May 2023 ALBO stock ended at $44.15. During the day the stock fluctuated 0% from a day low at $44.15 to a day high of $44.15.
90 days $43.57 $44.90
52 weeks $16.02 $45.23

Historical Albireo Pharma Inc prices

Date Open High Low Close Volume
Feb 08, 2023 $44.52 $44.55 $44.15 $44.23 234 002
Feb 07, 2023 $44.46 $44.74 $44.40 $44.59 178 167
Feb 06, 2023 $44.80 $45.13 $44.38 $44.59 210 723
Feb 03, 2023 $44.15 $45.23 $44.15 $44.95 502 012
Feb 02, 2023 $44.61 $44.71 $43.97 $44.55 222 200
Feb 01, 2023 $44.74 $44.77 $44.52 $44.70 160 207
Jan 31, 2023 $44.10 $44.76 $44.07 $44.66 444 426
Jan 30, 2023 $44.00 $44.15 $43.91 $44.10 432 281
Jan 27, 2023 $43.82 $44.08 $43.82 $44.07 846 186
Jan 26, 2023 $43.90 $44.01 $43.75 $43.95 342 921
Jan 25, 2023 $43.76 $44.01 $43.54 $43.90 878 830
Jan 24, 2023 $43.76 $43.90 $43.25 $43.76 561 941
Jan 23, 2023 $43.81 $43.91 $43.73 $43.80 689 675
Jan 20, 2023 $43.85 $43.93 $43.75 $43.81 367 000
Jan 19, 2023 $43.92 $44.09 $43.75 $43.88 302 878
Jan 18, 2023 $43.90 $44.10 $43.84 $43.88 265 500
Jan 17, 2023 $43.95 $44.10 $43.71 $43.90 378 500
Jan 13, 2023 $43.95 $44.40 $43.85 $43.90 451 613
Jan 12, 2023 $44.04 $44.29 $43.91 $43.94 791 900
Jan 11, 2023 $43.76 $44.25 $43.56 $44.10 1 220 000
Jan 10, 2023 $43.65 $44.06 $43.53 $43.85 1 261 490
Jan 09, 2023 $43.86 $44.36 $43.41 $43.85 6 285 391
Jan 06, 2023 $23.22 $23.32 $22.21 $22.82 113 500
Jan 05, 2023 $21.58 $23.56 $21.58 $23.00 120 032
Jan 04, 2023 $21.50 $22.48 $21.01 $21.82 118 645
Click to get the best stock tips daily for free!

About Albireo Pharma Inc

Albireo Pharma Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-th... ALBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT